The present disclosure relates to a safe, synergistic and optimized pharmaceutical composition that may find utility in management of hirsutism, wherein the composition comprises curcumin in a range of 0.01% w/w to 5% w/w, Cyperus rotundus in a range of 0.01% w/w to 5% w/w, green tea in a range of 2% w/w to 45% w/w,...

The present disclosure relates to a kit for screening a biomarker in a sample, said kit comprising: a support for placing the sample; a detecting agent; and a mean for multi-analyte profiling to detect and quantify the biomarker in the sample, wherein, the biomarker comprises a protein biomarker selected from the gr...

The present invention relates to the field of pharmaceutical composition. Specifically, the present invention relates to a safe and optimized pharmaceutical composition comprising Ginko biloba extract; Safed Musli extract; Cordiceps extract; Ginseng extract; Piperine; Ginger extract; and one or more pharmaceutically...

The present disclosure relates to a pharmaceutical composition for promoting healing of a wound, said composition including: Curcuma longa extract in an amount ranging from 1% to 8% by weight of the composition; Rubia cordifolia extract in an amount ranging from 1% to 8% by weight of the composition; Nanocurcumin in...

The present disclosure relates to cannabidiol (CBD). More specifically, the disclosure provides compositions and formulations comprising a therapeutically effective amount of cannabidiol or pharmaceutically acceptable salts thereof; optionally, one or more additional ingredients; and one or more pharmaceutically acc...

The present disclosure relates generally to the field of hair care compositions. Particularly, the present disclosure provides a herbal hair oil composition for stimulation of hair growth, control and prevention of hair fall. It further relates to a process of preparation of the herbal hair oil composition. ...